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In this study, we evaluated the activities of respiratory chain complexes and oxidative phosphorylation (OXPHOS) capacity of the heart to
gain insights into the pathological significance of mitochondrial dysfunction in chagasic cardiomyopathy (CCM). In a murine model of
Trypanosoma cruzi infection, biochemical and histochemical analysis of the cardiac mitochondria revealed deficiency of the respiratory chain
complexes (CI–CV) in infected mice; the inhibition of CI activity was more pronounced in the acute infection phase, CIII was constitutively
repressed throughout the infection and disease phase, and the CV defects appeared in chronic phase only. A substantial decline in cardiac
mtDNA content (54–60%) and mitochondria-encoded transcripts (50–65%) with disease development indicated that the alterations in
mtDNA contribute to the quantitative deficiencies in respiratory chain activity in chagasic hearts. The observations of a selective inhibition of
redox-sensitive CI and CIII complexes that are also the site of free radical generation in mitochondria, and the decline in cardiac mtDNA
content in infected mice, all support the free radical hypothesis of mitochondria dysfunction in CCM. Consequently, OXPHOS-mediated ATP
synthesis capacity of the cardiac mitochondria in infected mice was substantially reduced (37–50%), suggesting an energy homeostasis in the
affected tissue.
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1. Introduction common manifestations of disease is the slow progressionChagas disease is a pathological process induced by
human infections with the hemoflagellate protozoan Trypa-
nosoma cruzi and is a major health problem in the southern
parts of the American continent [1]. Among the most0925-4439/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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E-mail address: nigarg@utmb.edu (N. Garg).of myocarditis that might evolve into chagasic cardiomyop-
athy (CCM) signified by diffused inflammatory reactions,
hypertrophy, and fibrosis leading to ventricular dilation and
cardiac arrhythmia [2]. Most studies on the pathogenesis of
Chagas’ disease have postulated the crucial role of parasite
persistence in the development of clinical disease [3]. Others
have proposed that an autoimmune mechanism [4,5] inde-
pendent from parasite persistence is involved in the devel-
opment of pathogenic processes in chronic Chagas’ disease.
However, despite decades of research, limited information is
available on the cellular and molecular mechanisms by
which cardiovascular functions are adversely affected in T.
cruzi-infected patients and experimental models.
Infection by T. cruzi generally induces proinflammatory
cytokines (TNF-a, IL-1, and IL-6) that play an important
role in modulating host resistance to parasite. The prime
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control of parasitic infections is through the activation of
cytotoxic agents, including reactive oxygen species (ROS)
and nitrogen species (RNS) [6]. For example, TNF-a has
been shown to be effective in controlling parasite burden [7]
partly by enhancing the NO-dependent trypanocidal activity
of the activated macrophages [8]. The susceptibility of
trypanosomes to reactive species and the direct role of
ROS in limiting T. cruzi replication and survival in infected
cells and experimental animals have also been reported [9].
During the process of parasite destruction, the host cells
protect themselves from inflammatory mediators and reac-
tive species via the activation of a cascade of defense and
repair mechanisms that ensure cell survival [10,11]. How-
ever, when exposed to excessive insult, host components
(DNA, lipids, and proteins) may also be damaged, resulting
in inhibition of a variety of physiological functions, even-
tually leading to cell death [12,13]. Of note is the role of
TNF-a-mediated cytotoxic reactions in inducing pro-apo-
ptotic reactions, cell death, and tissue damage in T. cruzi-
infected murine hearts [14,15]. IL-1 and IL-6 have also been
associated with alterations in endothelial cell functions in
experimental and human CCM [16]. Further studies would
identify the host cellular and organelle functions that are
adversely affected by the inflammatory mediators and may
be of pathological importance in cardiovascular homeostasis
associated with CCM development.
The heart is highly dependent on mitochondria for the
energy required for its contractile and other metabolic
activities. Mitochondria represent 30% of the total volume
of cardiomyocytes and provide f 90% of the cellular ATP
energy through oxidative phosphorylation (OXPHOS). In-
terestingly, mitochondria are the targets of a variety of
endogenous and exogenous insults, including the inflam-
matory mediators. The damage of mitochondrial membrane
phospholipids, DNA, or proteins can have multiple effects
on mitochondria function, including increased permeability
of the mitochondrial membranes, loss of the mitochondrial
components (e.g. cytochrome c), dissipation of the mito-
chondrial membrane potential and protonmotive force, and
the decreased activity of the respiratory chain complexes
(RCC, CI–CV) [17–19]. The eventual outcome of mito-
chondrial abnormalities is the impairment of the OXPHOS
capacity, which is likely to have an adverse influence on
energy production and cardiac performance.
Recently, we demonstrated in a murine model of T. cruzi
infection and disease development, the accumulation of
irregular and swollen mitochondria that may also be dys-
functional [20]. The repression of a variety of transcripts
encoding components of the respiratory complexes sug-
gested that chagasic hearts might be compromised in their
respiratory activity [20]. In this study, we sought to deter-
mine (i) whether the activities of the respiratory complexes
is impaired during progressive cardiomyopathy in a murine
model of T. cruzi infection and disease development, and (ii)
if the mitochondrial respiratory chain defects disturb thecardiac energy status in infected mice? Our results support a
relationship between depletion of the mtDNA content and
expression, the loss in RCC activities, and the decline in
OXPHOS capacity with disease severity in infected murine
hearts. We discuss the potential contribution of CI and CIII
deficiencies in promoting free radical production and mito-
chondrial dysfunction in CCM.2. Materials and methods
2.1. Mice and parasites
Six- to eight-week-old male C3H/HeN mice (Harlan
Labs) were used in all experiments. The SylvioX10/4 strain
of T. cruzi and C2C12 cells (murine skeletal muscle hybrid-
oma cells) were purchased from American Tissue Culture
Collection (ATCC, Rockville, MD). T. cruzi trypomasti-
gotes were maintained and propagated by continuous in
vitro passage in C2C12 cells [21]. Mice were infected by
intraperitoneal injection of 50,000 culture-derived trypo-
mastigotes. Animal experiments were performed according
to the National Institutes of Health Guide for Care and Use
of Experimental Animals and approved by the UTMB
Animal Care and Use Committee.
2.2. Biochemical measurements
The myocardial content of DNA, RNA, and protein was
measured at different stages of infection and disease devel-
opment and expressed as mg/g wet weight [22].
2.3. Isolation of mitochondria
Mice were sacrificed during the immediate early (3–10
days post-infection, dpi), acute (15–40 dpi), and chronic
(>110 dpi) phases of infection and disease development.
Samples of heart ventricle and skeletal muscle were washed
and suspended in ice-cold isolation buffer (5 mM HEPES,
pH 7.2 containing 210 mM mannitol, 70 mM sucrose, 1 mM
EGTA, and 0.5% BSA (fatty acid-free), tissue/buffer ratio,
1:10 w/v) and immediately homogenized [20]. Homoge-
nates were centrifuged at 1000 g, 4 jC for 5 min and the
supernatant transferred to a new tube. The pellet was re-
suspended in isolation buffer, homogenized, and centrifuged
again as described above. The combined supernatants were
centrifuged at 8100 g for 15 min at 4 jC, the mitochon-
drial pellet re-suspended in isolation buffer (tissue/buffer,
1:1 ratio, w/v), and the aliquots stored at  80 jC. Protein
concentrations were determined by the Bradford method
[23].
2.4. Spectrophotometric evaluation of the RCC activities
The measurement of the specific activity of the RCC was
performed as described [24,25] with slight modifications. All
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mitochondrial proteins, and the linear change in absorbance
measured for 3 min. CI (NADH-ubiquinone oxidoreductase):
the reaction mixture consisted of 10 mM Tris–HCl pH 8.0
buffer, 80 AM 2,3-dimethoxy-5-methyl-6-decyl-1, 4-benzo-
quinone (DB), 1 mg/ml BSA, 0.25 mM KCN, and 0.4 AM
antimycin. After incubating mitochondria in the reaction
mixture at 30 jC for 5 min, oxidation of NADH (200 AM)
wasmonitored at 340 nm (e5.5mM 1 cm 1). CII (succinate-
ubiquinone oxidoreductase): mitochondria were incubated in
50 mM potassium phosphate buffer pH 7.4 containing 20 AM
succinate. After addition of assay mixture consisting of 50
AM 2,6-dichlorophenolindophenol (DCPIP), 2 mM KCN, 2
Ag/ml rotenone, 2 Ag/ml antimycin; 25 AM DB was mixed.
The reduction of DCPIP in association with CII-catalyzedDB
reduction was measured at 600 nm (e19.1 mM 1 cm 1). CIII
(ubiquinol-cytochrome c oxidoreductase): mitochondria
were suspended in 50 mM Tris–HCl buffer, pH 7.4 contain-
ing 1 mM EDTA, 250 mM sucrose, 2 mM KCN, and 50 AM
oxidized cytochrome c. After the addition of 80 AM reduced
DB (DBH2), reduction of cytochrome c was measured at 550
nm (e19.0 mM 1 cm 1). CII +CIII (succinate-cytochrome c
oxidoreductase): mitochondria were incubated in 40 mM
potassium phosphate buffer pH 7.4, 20 mM succinate, 0.5
mM EDTA, 2 mM KCN, and 30 AM cytochrome c. The
reduction of cytochrome c by CIII coupled to oxidation of
succinate through CII reaction was measured at 550 nm
(e19.0 mM 1 cm 1). CIV (cytochrome c oxidase): mito-
chondria (2 Ag protein) were permeabilized in 10 mM Tris–
HCl pH 7.0, 25 mM sucrose, 120 mM KCl, and 0.025% n-
dodecyl-h-D-maltoside, and 50 AM reduced cytochrome c
added. The oxidation of cytochrome c was measured at 550
nm (e19.0 mM 1 cm 1). Citrate synthase: mitochondria
were added to 100 mM Tris–HCl buffer pH 8, 0.3 mM acetyl
CoA, 100 AM 5,5V-dithio-bis 2-nitrobenoic acid (DTNB).
The reaction was initiated by 0.5 mM oxaloacetate. Citrate
synthase-catalyzed reduction of acetyl CoAwith oxaloacetate
in conjunction with DTNB reduction was monitored at 412
nm (e13.6 mM 1 cm 1). Specificity of the respiratory
complexes activities was determined by monitoring changes
in absorbance in the presence of the specific inhibitors: CI
(rotenone, 6.5 AM), CII (sodium malonate, 10 mM), CIII
(antimycin, 5 Ag/ml), and CIV (KCN, 1 mM).
2.5. Blue native-polyacrylamide gel electrophoresis
(BN-PAGE) and histochemical staining
Mitochondria for BN-PAGE were isolated in 20 mM
Tris–HCl pH 7.4, 250 mM sucrose, 2 mM K2EGTA.
Mitochondrial pellets (500 Ag protein) were suspended in
60 Al extraction buffer (50 mM imidazole pH 7.0, 5 mM
aminocaproic acid, 50 mM NaCl) containing protease
inhibitor cocktail [20] and the mitochondrial membranes
were solubilized by adding 6 Al of freshly prepared 10%
dodecyl maltoside (protein/detergent ratio, 1:6) [26]. Fol-
lowing incubation on ice for 30 min, samples were centri-fuged at 13,000 g, 4 jC for 15 min. The supernatants (70
Al) were transferred to a clean tube, and 3.5 Al of 5%
Coomassie brilliant blue G-250 suspension in 0.5 M amino-
caproic acid, 10% glycerol (Coomassie/detergent ratio, 1:4)
added. A 5–12% polyacrylamide gradient gel with 4%
stacker gel for electrophoresis was poured into a BioRad
mini-gel apparatus and samples loaded immediately. Elec-
trophoresis was run at 4 jC, 15 min each at 125 and 250 V
using separate anode (25 mM imidazole HCl pH 7.0) and
cathode (50 mM Tricine, 7.5 mM imidazole, pH 7.0, 0.02%
Coomassie G-250) buffers. After 30 min, cathode buffer
without Coomassie G-250 was added and electrophoresis
continued at 250 V for 40 min [26].
Catalytic staining reactions to evaluate the activity of the
respiratory complexes were performed immediately after the
first dimension BN-PAGE [27,28]. Briefly, CI activity was
determined by incubation of the gel slices with 1 mM Tris–
HCl, pH 7.4, 0.1 mg/ml NADH, and 2.5 mg/ml nitro-
bluetetrazolium at room temperature. For the detection of
CII activity, gel slices were incubated with 1.5 mM phos-
phate buffer pH 7.4 containing 5 mM EDTA, 10 mM KCN,
0.2 mM phenazine methosulfate, 84 mM succinate, and 10
mM nitrobluetetrazolium. CIV activity was estimated by
incubating the gel slices in dark with 50 mM phosphate
buffer pH 7.4, 0.5 mg/ml 3,3V-diaminobenzidine tetrahydro-
chloride, 75 mg/ml sucrose, 2 Ag/ml catalase, and 1 mg/ml
reduced cytochrome c. To obtain the CV (F1F0 ATP syn-
thase) activity, gel slices were incubated in dark in 35 mM
Tris–HCl pH 7.8 containing 270 mM glycine, 14 mM
MgSO4, 0.2% Pb(NO3)2, and 8 mM ATP. For the preser-
vation of the color of CI-, CII-, and CIV-reacting bands, gel
slices were fixed in 50% methanol, and 10% acetic acid, and
stored in 10% acetic acid. The white–black color of CV was
visualized and photographed immediately. Densitometric
quantitation of all colored bands was performed on a
FluorChem 8800 (Alpha Innotech) image-analyzing system.
2.6. mtDNA content
The mtDNA content in infected murine hearts was exam-
ined by Southern blot analysis. Cardiac tissue samples were
homogenized in 10 mM Tris HCl, pH 7.5, 10 mM EDTA, 0.1
M NaCl, and proteins in tissue lysates digested by incubation
overnight at 55 jC in the presence of 0.5% SDS, 20 Ag/ml
Proteinase K. After digestion of the cellular RNAwith 5 Ag/
ml RNase A for 1 h at 37 jC, samples were extracted twice
with phenol/chloroform/isoamylalcohol (24:24:1) and DNA
purified by ethanol precipitation. DNA was digested with
NcoI or BamHI restriction enzymes, separated on 0.8%
agarose gel, and transferred to zeta probe membrane (Bio-
Rad). The [32P]-labeled COX2 and b-actin cDNA probes
were generated by random primer labeling in the presence of
5 Al of [a32P] dATP (3000 ACi/mmol, 10 ACi/Al, Amersham,
Piscataway, NJ). The membranes were hybridized with
COX2 probe at 60 jC overnight, washed, exposed to a
phosphorimaging screen, and the images captured using a
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vale, CA). After stripping of the COX2 probe, same mem-
branes were hybridized with b-actin probe. The band
intensities were compared by densitometric analysis.
2.7. Mitochondria-encoded gene expression
We examined mitochondria-encoded gene expression by
Northern blotting. Total RNA from cardiac tissue samples
was extracted by acid guanidinium-thiocyanate method [29]
with slight modifications [20]. Samples (5 Ag total RNA)
were denatured in 50% formamide/2 M formaldehyde,
electrophoresed in 1% agarose gel containing 2 M formal-
dehyde in 4-morpholinepropanesulfonic acid (MOPS) buff-
er and transferred to zeta probe membrane. The membranes
were hybridized with [32P]-labeled cDNA probes at 42 jC
for 24 h followed by washing in 0.1 SSC with 0.1% SDS
at 55jC. After exposure to a phosphorimaging screen,
images were captured as above. All cDNAs used as probe
for Southern and Northern blotting were amplified by RT-
PCR using gene-specific primer pairs (listed in Table 1) with
total RNA isolated from C57BL/6 mouse as template. The
cDNA amplicons were cloned in Topo (T) vector, and
confirmed by restriction digestion and sequencing at the
Recombinant DNA Core Facility at UTMB.
2.8. Mitochondrial ATP production rate
Freshly harvested cardiac tissue samples were homoge-
nized in 50 mM Tris pH 7.2 containing 100 mM KCl, 5 mM
MgCl2, 1.8 mM ATP, 1.0 mM EDTA and mitochondria
isolated as above. The ATP production capacity of the freshly
isolated mitochondria was monitored by a firefly luciferase
method [30] using a TD-20/20 Luminometer (Turner
Designs, Sunnyvale, CA). Briefly, 800 Al of ATP monitoring
reagent consisting of 15 mM potassium phosphate pH 7.0,
150 mM sucrose, 2 mM MgAc2, 0.5 mM EDTA, 2.5 Ag/mlTable 1
Genes analyzed in this study by Southern or Northern blotting
Gene
Name
Product GenBank
Accession #
ORF
(bp)
Mitochondria-encoded genes
Cytb cytochrome b V00711 1143
AP6 ATP synthase subunit 6 V00711 681
AP8 ATP synthase subunit 8 V00711 204
ND5 NADH oxidoreductase subunit 5 V00711 1824
ND2 NADH oxidoreductase subunit 2 V00711 1038
ND1 NADH oxidoreductase subunit 1 V00711 948
ND4L NADH oxidoreductase subunit 4L V00711 294
COX1 cytochrome c oxidase subunit 1 V00711 1545
COX2 cytochrome c oxidase subunit 2 V00711 684
Nuclear encoded genes
b-Actin cytoplasmic h-Actin M12481 1050
GAPDH glyceraldehyde phosphate
dehydrogenase
M32599 1228
ORF: open reading frame.luciferase, 20 Ag/ml D-luciferine, and 0.5 mg/ml BSA was
aliquoted in 1 ml cuvettes. After 5 min incubation, 50
Al mitochondria (f 100 Ag tissue weight, 3–5 Ag protein)
and 50 Al 12.5 mM ADP was added and the assay monitored
for 5 min in the presence of one of the following substrate
combinations: 15 mM glutamate + 15 mM succinate; 30 mM
glutamate + 20 mM malate; 31.5 mM TMPD+7 mM ascor-
bate; 2.5 mM succinate + 2 mg/l rotenone; and 2.5 mM
succinate. All assays were monitored in triplicate samples,
and the results are presented as nmol ATP/min/mg wet tissue
weight.
2.9. Statistical analysis
Qualitative data are expressed as raw data or percentages
and compared using chi-square tests. Quantitative data is
presented as meanF S.D. The Student–Newman–Kreuls
test was used for statistical evaluation of mean values for
experimental and control animals. The level of significance
were taken as P < 0.05.3. Results
3.1. Impairment of the RCC activities in the myocardium of
T. cruzi-infected mice
Previously, we demonstrated that C3H/HeN mice infected
with the SylvioX10/4 strain of T. cruzi mimic the symptoms
of human disease and provide an excellent experimental
model for understanding the pathogenesis of progressive
CCM. The course of disease development in these mice is
divided into immediate early phase (3–5 dpi) of parasite
invasion and initiation of innate inflammatory responses,
acute phase (20–45 dpi) of parasite replication and activation
of adaptive immune responses, followed by the progressive
disease phase (>110 dpi) marked by minimal parasite burden,Forward primer
(5V! 3V)
Reverse primer
(5V! 3V)
Amplicon
(bp)
gttcgcagtcatagccacag ggcggaatattaggcttcgt 596
ggattcccaatcgttgtagc gggtgaatacgtaggcttgaa 601
tcatcacaaacattcccactg ggggtaatgaatgaggcaaa 112
tcctactggtccgattccac aatgctaggcgtttgattgg 604
cctatcacccttgccatcat tgagggatgggttgtaagga 595
tcccctaccaataccacacc acggaagcgtggataagatg 583
tgccatctaccttcttcaacc tttggacgtaatctgttccgta 270
ggtcaaccaggtgcactttt ggtgcccaaagaatcagaac 598
atggcctacccattccaact ttcagagcattggccataga 594
ccagatcatgtttgag gtccagacgcaggatg 170
tggcaaagtggagattgttg ttcagctctgggatgacctt 600
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generation in the myocardium [20]. The accumulation of
irregular and swollen mitochondria and repression of tran-
scripts for subunits of the respiratory complexes with pro-
gressive disease development [20] suggested that the activity
of the RCC might be compromised in the myocardium of
infected mice. To determine if such is the case, we evaluated
the enzymatic activities of the respiratory complexes in the
myocardium of infected mice.
We observed a substantial decline in the activity of the
selective respiratory complexes in the myocardium of
infected mice during disease progression (Fig. 1). CI
exhibited earliest and strongest repression in response to T.
cruzi infection; we observed a 38% loss in CI activity at 3 dpi
and a 47–57% decline during 25–40 dpi relative to controls.
With control of acute parasitemia, however, CI activity was
recovered substantially, even though statistically significant
loss in activity (f 18%, P>0.05) persisted throughout the
disease phase (Fig. 1). CIII specific activity diminished in
infected murine hearts throughout the infection and disease
phase; a 39–42% decrease in activity was observed during
the acute phase, while 52–60% loss in CIII activity persisted
during the chronic disease phase (Fig. 1). Similar to CIII,
infected murine hearts exhibited a decrease (23–42%) in
coupled CII + CIII activity during the entire course of infec-
tion and disease development. It should be noted that in
normal mitochondria, CII catalyzes the rate-limiting step in a
coupled CII + CIII assay [31,32]. In our experiments, we didFig. 1. Deficiency of respiratory complexes in the myocardium of T. cruzi-infected
(SylvioX10/4 strain, 50,000 parasites/mouse). The activities of respiratory com
mitochondria isolated from normal mice and T. cruzi-infected mice sacrificed at v
the oxidation of NADH (CI) and cytochrome c (CIV), and the reduction of DC
methods). Specific activity (nmol/min/mg protein) was calculated as meanF S.Dnot observe any alterations in CII activity (Fig. 1), thus
suggesting that severe inhibition of CIII might contribute to
overall decline in coupled CII + CIII activity. CIVappeared to
be most resistant to T. cruzi-induced changes; we observed a
14–36% decline in CIV activity in infected murine hearts as
compared to controls. In late chronic phase (180 dpi), CIV
activity was restored to the levels similar to that detected in
control mice (Fig. 1). Similar levels of CII activity in all
cardiac mitochondria samples extracted from infected and
normal tissues confirm the comparable efficiency of mito-
chondria isolation in different experiments (Fig. 1). In skel-
etal muscle mitochondria of infected mice, except for a
decline in CI activity (40% inhibition), we observed no
statistically significant impairment of CII, CIII, and coupled
CII + CIII activities at all stages of infection and disease
progression (unpublished observations).
3.2. Histochemical staining confirmed the RCC dysfunction
in chagasic myocardium
One limitation with the estimation of enzymatic activ-
ities by spectrophotometric method in tissue homogenates
and partially purified mitochondria is the detection of
cellular activities that may not be specific to mitochondrial
respiratory complexes. To overcome this limitation, we
performed BN-PAGE analysis and quantitated the activities
of the RCC by catalytic staining followed by densitometric
analysis. To correct for the differences in loading of themice. C3H/HeN mice were infected by intraperitoneal injection with T. cruzi
plexes CI–CIV and coupled CII + CIII activity were measured in cardiac
arious time-points post-infection. The complexes activity was monitored by
PIP (CII) and cytochrome c (CIII and CII +CIII) (details in Materials and
. obtained from duplicates estimated in three independent experiments.
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staining was expressed relative to the Coomassie-stained
complex (Fig. 2).
Histochemical staining of BN gels provided evidence for
the loss of respiratory complex activities with progressive
disease development in the myocardium of infected mice
(Fig. 2). Interestingly, catalytic staining revealed a >50%
reduction in CI activity during the acute phase and recovery
of CI activity after the acute infection phase. However, there
was a significant difference in the extent of improvement;
the spectrophotometric estimations of CI activity suggested
up to 40% recovery of the CI activity in chronically infected
murine hearts (150–180 dpi) as compared to that measured
during the acute phase (25–40 dpi), whereas catalytic
staining indicated that only 20% of CI activity was retrieved
in chronically infected mice (Fig. 1 versus Fig. 2A,C).
These discrepancies could be due to differences in extrac-
tion procedures and the sensitivity of the measurement
method. However, given that the spectrophotometric assay
detects other cellular activities, while BN-PAGE specifically
measures the OXPHOS enzyme, it is likely that the latter is
a more reliable measurement of CI activity. The histochem-
ical changes in the specific activity of CIVat different stages
of infection and disease progression were similar to that
detected by spectrophotometric methods, while no change in
CII activity was observed during the entire course of
infection and disease development (data not shown). Cata-Fig. 2. Histochemical staining of blue-native gels confirms the loss of CI and C
cardiac tissue of normal and T. cruzi-infected mice sacrificed at 3, 25, 40, 150, and
in the mitochondria preparations were resolved by BN-PAGE. The BN gels we
individual complexes were subjected to enzymatic colorimetric reactions (panel A
the respiratory complexes. The histochemically stained and Coomassie blue-staine
data were estimated as the ratio between the arbitrary units obtained for catalytic
The data present mean values obtained from at least three independent experimenlytic staining for CIII failed to provide reproducible results
with normal murine tissues and is, therefore, not included in
the study. Interestingly, acutely infected mice exhibited an
increase in CV activity (14–30%) when a substantial loss in
the activity of other respiratory complexes was noted (Fig.
2A and C). However, with progressive disease development,
>30% loss in CV activity was observed in the myocardium
of infected mice relative to normal controls (Fig. 2A and C).
Together, spectrophotometric and histochemical staining
assays confirm the deficiencies of RCC in response to T.
cruzi infection in murine myocardium.
3.3. Aberrations in mtDNA content and mitochondria-
encoded gene expression in chagasic mice
A loss in mitochondrial respiratory complexes activities
is often caused by damage of the mtDNA and/or changes in
the expression of mitochondria-encoded subunits of the
respiratory complexes. To determine if mtDNA is altered
with disease progression, we estimated mtDNA content in
infected murine hearts at various stages of disease develop-
ment. Southern blot analysis was performed using mtDNA-
specific COX2 probe and nuclear DNA (nDNA)-specific b-
actin probe and the intensity of the 7 and 16 kb mtDNA
bands recognized by COX2 probe (Fig. 3A) and 2 kb nDNA
band recognized by b-actin probe (Fig. 3B) estimated by
densitometric analysis. mtDNA content in normal andV activities in cardiac tissue of T. cruzi-infected mice. Mitochondria from
180 dpi were isolated by differential centrifugation. The CI-CV complexes
re either stained with Coomassie blue (panel B) or gel slices containing
) as described in Materials and methods. (C) Quantitation of the activity of
d areas of the RCC were evaluated by densitometric analysis. Quantitative
stained complex and the corresponding Coomassie stained complex  100.
ts. DPI, days post-infection.
Fig. 3. Southern blot analysis demonstrates a reduction in mtDNA levels in T. cruzi-infected murine hearts. C3H/HeN mice were infected with culture-derived
T. cruzi trypomastigotes (as above). Total DNAwas isolated from the cardiac tissue of normal (lanes 1–3) and infected mice sacrificed during acute (25 dpi,
lanes 4–6), or chronic (150 dpi, lanes 7–9) phases of infection and disease development, respectively, and resolved by agarose gel electrophoresis. DNAwas
transferred to nylon membrane and hybridized with [32P] labeled mitochondria-encoded COX2 probe (A). Membrane was exposed to a phosphorimaging
screen for 24 h and the signal captured on a phosphorimager. After stripping the first probe, membrane was hybridized with nuclear-encoded b-actin probe
(Panel B). (D). Quantitation of mtDNA content in infected murine hearts. The phosphorimages of COX2 and b-actin-hybridized DNA bands were quantitated
on a FluorChem 8800 Image Analyzing System. The quantitative data were estimated as the ratio between COX2-signal and the corresponding b-actin signal
 100. The data present mean values obtained from three independent experiments using heart tissue of at least two mice/experiment. Abbreviations: U, uncut;
B, BamHI; N, NcoI, and dpi, days post-infection. The position of the COX2 gene on murine mitochondrial genome is shown (panel C).
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obtained with COX2 probe to b-actin probe (Fig. 3D). The
acutely infected murine hearts (25 dpi) exhibited statistically
insignificant changes in mtDNA content relative to normal
controls (Fig. 3A and D). The level of mtDNA was,
however, considerably decreased with progressive disease
development in infected mice. Densitometric analysis sug-
gested a 54–60% decline in mtDNA content in chronically
infected murine hearts (150 dpi) in comparison to normal
controls.
Next, we measured the level of transcripts for mitochon-
dria-encoded respiratory subunits by Northern blot analysis
(Fig. 4). The intensity of mitochondria-encoded transcripts
was estimated by densitometric analysis and normalized to
rRNA (18S and 23S) content. Despite normal levels of
mtDNA (Fig. 3A and D), the acutely infected murine hearts
exhibited a deficiency of mitochondria-encoded transcripts
(Fig. 4). We observed a >50% decrease in mitochondria-
encoded CI (ND1, ND2, and ND4L) and CIV (COX1 and
COX2) mRNAs in infected murine hearts (25–40 dpi)
relative to controls (Fig. 4). The decline in the level of
CI- and CIV-transcripts was consistent with the alterations
in the enzymatic activity of these complexes at 25–40 dpi
(Figs. 1 and 2). In the myocardium of chronically infected
mice (150–180 dpi), expression of all of the mitochondria-
encoded genes that were examined was significantly re-
duced (up to 80%) compared to normal controls (Fig. 4B).
The repression of the mitochondria-encoded transcripts wasconsistent with the depletion of mtDNA in chagasic myo-
cardium (Fig. 3). Similar steady-state levels of transcripts
for cardiac h-actin and glyceraldehyde phosphate dehydro-
genase confirmed the use of similar amounts of RNA for all
samples (data not shown).
Considering the substantial repression of the mitochon-
dria-encoded transcripts in infected hearts, we predicted that
quantity or assembly of the respiratory complexes might be
adversely affected in infected mice. To determine if such is
the case, we resolved the RCC on BN gels, quantitated by
densitometric analysis, and calculated the intensity of each
complex per mg wet tissue weight. As expected, the level of
mitochondria-encoded respiratory complexes in infected
murine hearts was significantly reduced with disease sever-
ity (data not shown). No alterations were observed in
molecular size of the respiratory complexes in infected
murine hearts relative to controls (Fig. 2B), suggesting that
the expression of the mitochondria-encoded genes is essen-
tial for the maintenance and assembly of the respiratory
chain complexes. The observation of a decline in catalytic
staining of the respiratory complexes in infected murine
hearts (Fig. 2A) compared to the amount of protein detected
by Coomassie (Fig. 2B), however, suggests that the assem-
bled complexes are not enzymatically functional. Together,
Southern, Northern, and BN-PAGE analyses have provided
evidence for the alteration and repression of the genes
encoded by mitochondrial genome and its likely role in
assembly and activity of the respiratory complexes during
Fig. 5. OXPHOS capacity of the cardiac mitochondria in T. cruzi-infected mice. Cardiac mitochondria from normal and infected mice sacrificed at various time-
points post-infection were isolated by differential centrifugation and immediately used for OXPHOS-mediated ATP synthesis rates, as described in Materials
and methods. Luminescence was recorded for 5 min at 30 s intervals with a 1 s integration time. Data presented as mmol ATP/min/g tissue weight was
calculated as meanF S.D. obtained from triplicate samples (panel B). General schematic representation of mitochondrial respiration including the RCC of the
OXPHOS pathway is shown in panel A. Oligomycin and atractyloside (used in this study) inhibit the activity of ATP synthase and ATP translocase,
respectively, which are necessary for mitochondrial ATP production.
Fig. 4. (A). Northern blot analysis showed the alterations in mitochondria-encoded gene expression in the myocardium of T. cruzi-infected mice. Total RNA
isolated from whole hearts of normal and infected mice sacrificed at various time-points post-infection was resolved by denaturing agarose gel electrophoresis.
RNAwas transferred to nylon membrane and hybridized with [32P] labeled, mitochondria-specific Cytb, AP6, AP8, ND5, ND2, ND1, ND4L, COX1, and COX2
cDNA probes. (B). Quantitation of mitochondria-encoded transcripts. The phosphorimages of mitochondria-encoded transcripts in normal and infected murine
hearts were quantitated by densitometric analysis. The quantitative data were normalized to the amounts of 18S and 23S rRNA and represent the mean
valuesF S.D. obtained from three independent experiments.
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the myocardium of mice.
3.4. Impaired OXPHOS capacity of the cardiac mitochon-
dria in T. cruzi-infected mice
The ultimate goal of this study was to determine whether
the decline in respiratory chain activity affects the cardiac
energy status in infected mice. For this, we measured the
OXPHOS-mediated ATP synthesis capacity of the cardiac
mitochondria in the presence of substrates that donate
electrons within the OXPHOS pathway (Fig. 5A). The
specificity of ATP synthesis by mitochondria was demon-
strated by a f 95% reduction in ATP synthesis upon
addition of dinitrophenol (a strong mitochondrial uncoupler)
in all experiments irrespective of the substrate used. The
residual ATP synthesis ( < 10%) in the presence of oligo-
mycin and atractyloside, the inhibitors of F1F0 ATP synthase
and ATP translocase, respectively, was possibly due to the
activity of the citric acid cycle and glycolytic pathway.
During the immediate early phase of parasite invasion
and infection, the murine myocardium appeared to be fully
capable of synthesizing ATP. The ATP production capacity
of the cardiac mitochondria harvested at 3–8 dpi was
either similar to or higher than that observed in controls
with all the substrates examined (Fig. 5B). The acutely
infected myocardium (21–45 dpi) showed a 37–40%
decrease in mitochondrial ATP production capacity with
glutamate + succinate, succinate, and succinate + rotenone
substrates relative to controls (Fig. 5B). With progression
to the disease phase, the extent of mitochondrial dysfunc-
tion was increased. The myocardium of chronic mice
sacrificed at >110 dpi exhibited 36% (P < 0.05), 45%
(P < 0.05), and 50% (P < 0.05) decline in ATP synthesis
capacity, with glutamate + succinate, succinate, and succi-
nate + rotenone substrates, respectively, relative to controls
(Fig. 5B). Overall, these data validate the loss in
OXPHOS-mediated ATP synthesis capacity of the cardiac
mitochondria with progressive disease development in
infected mice and suggest that the chagasic hearts might
be compromised in terms of energy available for contrac-
tile and other metabolic functions.4. Discussion
The current study is novel in that the molecular and
biochemical changes in respiratory complexes and OXPHOS
capacity of the chagasic myocardium were evaluated to gain
insights into the significance of mitochondrial respiration
defects in CCMpathogenesis. Our data clearly show selective
inhibition of the respiratory chain complexes in the myocar-
dium of infected mice. The alterations in CI activity were
more pronounced during the acute infection phase, CIII and
coupled CII + CIII activities were constitutively repressed
throughout the infection and disease phase, and the deficien-cy of CV enzyme appeared during the chronic disease phase
(Figs. 1 and 2). The magnitude of decline in respiratory
complexes was sufficient to account for the concurrent loss of
mitochondrial OXPHOS-mediated ATP synthesis capacity,
suggesting energy homeostasis in chagasic myocardium.
Various in vitro and in vivo studies indicate that inflammatory
intermediates and reactive species, elicited by the host to limit
parasite survival [6–9], could cause mitochondria injuries
and respiratory chain dysfunction [17–19,33,34]. Addition-
ally, inhibition of CI and CIII complexes can result in increase
in free radical generation [34–37]. Our data indicate a
plausible mechanism by which T. cruzi infection-induced
mitochondrial injuries might lead to sustained free radical
generation and respiratory dysfunction in CCM.
The current data demonstrating the selective decline in
respiratory complexes (Figs. 1 and 2) suggests that reactive
radicals contribute to the loss in mitochondrial function. A
large body of studies indicates that inflammatory cytokines
and reactive intermediates (ROS, RNS) induced to control T.
cruzi survival in the host [7–9] can also damage host
cellular and organelle function [12,13]. Respiratory com-
plexes are particularly sensitive to inhibition [33,34] arising
from reactive species-mediated mitochondrial injuries [17–
19]. The significance of the current study is that T. cruzi
infection does not induce unilateral reduction in enzyme
activities, but rather specific inactivation of the redox-
sensitive CI and CIII complexes. CI and CIII contain
prosthetic clusters (4Fe, 4S) that are capable of interacting
with reactive species resulting in oxidative damage of the
respiratory chain components and enzyme inactivation [36].
The consistent inactivation of CI and CIII complexes in
infected murine hearts along with our recent observations
indicating increased carbonylation of several subunits of CI,
CIII, and CV complexes in the infected myocardium (un-
published data) provides potential mechanism for the
rational design of methods to test the contribution of
reactive radicals in mitochondrial dysfunction in CCM.
Several studies have previously demonstrated that the
mitochondrial respiratory chain is a source of ROS [38,39].
CI and CIII complexes are the prime sites for electron
leakage to molecular oxygen resulting in free radical gen-
eration in mitochondria [34–37]. The rate of mitochondrial
free radical production is inversely proportional to the rate
of electron transport, exponentially increasing when CI or
CIII complexes of the electron transport chain function at
sub optimal level [36]. Our finding of a loss in CI activity in
cardiac mitochondria in response to parasite infection (3
dpi) and replication (21–45 dpi) implies that CI might be a
potential site of free radical generation in acute mice.
Interestingly, consistent deficiencies of CIII activity in the
cardiac mitochondria, but not in skeletal muscle mitochon-
dria of the infected mice (unpublished data), suggests CIII
as the likely site for sustained free radical generation in the
myocardium of infected mice. Future studies aimed at
elucidating the events leading to CI and CIII inhibition will
indicate strategies to effectively prevent the inactivation of
G. Vyatkina et al. / Biochimica et Biophysica Acta 1689 (2004) 162–173 171these complexes and allow the assessment of the role of
these complexes in sustained oxidative stress in CCM.
Our data demonstrating the depletion of mtDNA
content with progressive disease development in infected
myocardium (Fig. 3) provides further support for the free
radical hypothesis of mitochondrial dysfunction in CCM.
The mitochondrial biogenesis defects leading to a decline
in number of mitochondria/cell as well as the mtDNA
damage resulting in deletions and/or degradation of DNA
can all contribute to a decrease in intact mitochondrial
genome. The detection of a similar number of mitochon-
dria in cardiac sections of infected mice exhibiting
increasing severity of chronic disease and in normal
mice, as determined by transmission electron microscopic
analysis [20], suggests that mitochondrial biogenesis
defects may not be the probable cause for mtDNA
depletion in infected mice. Instead, numerous studies
strongly support reactive species to play a prominent role
in mtDNA deletions through oxidative damage. mtDNA
is highly susceptible to damage by reactive oxidants due
to a lack of protective histones [40]. Accumulation of
significantly higher levels of DNA oxidation product 8-
hydroxydeoxyguanosine in mtDNA compared to nuclear
DNA and increased degradation of the mutated mtDNA
is shown in a variety of in vitro and in vivo conditions
of oxidative stress [41–43]. Given the inhibition of
redox-sensitive CI and CIII complexes that are also the
prime site for free radical generation in mitochondria, it
is reasonable to postulate that ROS-induced alterations
resulting in deletions or degradation of oxidatively dam-
aged mtDNA contribute to mtDNA depletion in chagasic
myocardium.
The magnitude of the mtDNA defects in chronic myo-
cardium (Fig. 3) was proportional to the quantitative defi-
ciencies of all of the mitochondria-encoded transcripts
examined (Fig. 4) and to the loss in the activity of the
respiratory complexes (Figs. 1 and 2). These observations
suggest that mtDNA defects are at least partially responsible
for the respiratory chain dysfunction in chagasic myocardi-
um. This notion is supported by others documenting an
intimate link between mtDNA depletion and a decrease in
respiratory complexes activities and OXPHOS capacity in
failing hearts [44]. Recent studies using cultured neuronal
cells or cardiomyocytes have also demonstrated that ROS-
mediated mtDNA damage can result in alterations in mito-
chondria-encoded gene expression and deficiency of mito-
chondrial respiration [45,46].
The ultimate goal of these studies was to determine the
physiological effect of mitochondrial defects on cardiac
energy status. The respiratory chain-mediated oxidation of
the high-energy carriers (NADH and FADH2) and phos-
phorylation process provides >90% of the cellular ATP
energy for the contractile and other metabolic functions of
the heart. A defect in any component of the respiratory chain
may compromise OXPHOS capacity and cardiac energy
availability. Considering that the inhibition of CI activity incardiac tissue of the infected mice was equivalent to that
detected in skeletal muscle, CI defects may not contribute to
altered ATP synthesis efficiency in the myocardium. This is
not surprising, as a greater than 85% inhibition of CI in
fibroblast cell lines is required before an impairment of
mitochondrial respiration was observed [47]. We surmise
that inhibition of the CIII and CV activities might be the
likely cause for the loss in mitochondria ATP production
capacity in the myocardium with progressive CCM. The
extent of loss in cardiac mitochondria capacity to produce
ATP was increased with disease severity, suggesting energy
homeostasis in CCM.
In conclusion, the observations of a selective inhibition
of redox-sensitive CI and CIII complexes that are also the
site of free radical generation in mitochondria suggest that
free radical-mediated oxidative damage contribute to the
loss of mitochondria function in the myocardium of chaga-
sic mice. The heart-specific progressive and sustained
deficiencies of the respiratory chain activity leading to an
overall decline in mitochondrial energy synthesis capacity
imply the pathophysiologic significance of the OXPHOS
dysfunction in CCM.
Finally, mtDNA base substitution mutations and mtDNA
rearrangement due to deletions or insertions have been
linked to a variety of heart diseases. An accumulation of
the mtDNA deletions in the myocardium is frequently
linked to cardiac hypertrophy [48,49], conduction block
[50,51], or heart failure [44]. Furthermore, there is now a
consensus view that mutations in mtDNA and abnormalities
in mt function are associated with ischemic heart disease
and dilated cardiomyopathy [52–54]. This study, to our
knowledge, is the first to provide evidence for depletion of
mtDNA, deficiencies of mitochondria-encoded gene expres-
sion, and defects in mitochondrial respiratory chain-associ-
ated OXPHOS capacity with CCM development in mice.
Future studies could determine whether the impaired mito-
chondrial tolerance because of oxidative stress result in
increased vulnerability of mitochondrial DNA and energet-
ics and thereby constitute a mechanism in myocardial
dysfunction in CCM.Acknowledgements
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